George Ng

Insider Reports History

Location
C/O Sorrento Therapeutics, Inc., 6042 Cornerstone Court West, Suite B, San Diego, CA
Signature
/s/ George Ng, by John J. Wolfel, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by George Ng:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Calidi Biotherapeutics, Inc. Director Common Stock 18.5K $33.4K $1.80 Sep 12, 2023 Direct
Processa Pharmaceuticals, Inc. Chief Executive Officer, Director Common Stock 87.2K $18.3K $0.21 Jul 24, 2025 George Ng IRRA FBO: George Ng
Calidi Biotherapeutics, Inc. Director Common Stock 9.55K $17.2K $1.80 Sep 12, 2023 By Peng Ventures, LLC
Processa Pharmaceuticals, Inc. Chief Executive Officer, Director Warrants 43.6K $9.16K $0.21 Jul 24, 2025 George Ng IRRA FBO: George Ng
Processa Pharmaceuticals, Inc. Chief Executive Officer, Director Common Stock 20K $4.2K $0.21 Jul 24, 2025 Ng Cha Family Trust
Processa Pharmaceuticals, Inc. Chief Executive Officer, Director Stock Options (Right to Buy) 768K Oct 1, 2025 Direct
Processa Pharmaceuticals, Inc. Chief Executive Officer, Director Restricted Stock Units 256K Oct 1, 2025 Direct
TuHURA Biosciences, Inc./NV Director Options (Right to Buy) 51.3K Jan 2, 2025 Direct
Kintara Therapeutics, Inc. Director Common Stock 0 Oct 18, 2024 Direct

Insider Reports Filed by George Ng

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PCSA Processa Pharmaceuticals, Inc. Oct 1, 2025 2 $0 4 Oct 3, 2025 Chief Executive Officer, Director
PCSA Processa Pharmaceuticals, Inc. Jul 24, 2025 0 $0 4/A Sep 18, 2025 Chief Executive Officer, Director
PCSA Processa Pharmaceuticals, Inc. Jan 27, 2025 2 $0 4/A Feb 18, 2025 Chief Executive Officer, Director
HURA TuHURA Biosciences, Inc./NV Jan 2, 2025 1 $0 4 Jan 6, 2025 Director
KTRA Kintara Therapeutics, Inc. Oct 18, 2024 3 $0 4 Oct 22, 2024 Director
KTRA Kintara Therapeutics, Inc. Oct 18, 2024 0 $0 3 Oct 22, 2024 Director
PCSA Processa Pharmaceuticals, Inc. Jan 30, 2024 1 $27K 4 Jan 31, 2024 Chief Executive Officer, Director
PCSA Processa Pharmaceuticals, Inc. Oct 12, 2023 1 $25K 4 Oct 12, 2023 Chief Executive Officer, Director
PCSA Processa Pharmaceuticals, Inc. Oct 10, 2023 1 $25K 4 Oct 10, 2023 Chief Executive Officer, Director
CLDI Calidi Biotherapeutics, Inc. Sep 12, 2023 0 $0 3 Sep 25, 2023 Director
PCSA Processa Pharmaceuticals, Inc. Aug 8, 2023 2 $0 4 Aug 9, 2023 Chief Executive Officer
PCSA Processa Pharmaceuticals, Inc. Aug 8, 2023 0 $0 3 Aug 9, 2023 Chief Executive Officer